Arterial infusion therapy with low-dose cisplatin and continuous 5-fluorouracil for isolated hepatic recurrence of gastric carcinoma

International Journal of Clinical Oncology

Volumn 5, Issue 3, 2000, Pages 192-194

  Akamo, Yoshimi ^a   Takeyama, Hiromitsu ^a   Mohri, Noriaki ^a   Teranishi, Futoshi ^a   Manabe, Tadao ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Arterial infusion therapy; Gastric carcinoma; Isolated hepatic recurrence; Low dose CDDP and continuous 5 FU; Quality of life

Indexed keywords

CISPLATIN; FLUOROURACIL;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; STOMACH CARCINOMA;

EID: 0033917828     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012037     Document Type: Article

References (14)

1. Okuyama K, Isono K, Juan I, et al. (1985) Evaluation of treatment for gastric cancer with liver metastasis. Cancer 55:2498-2505
2. Akamo Y, Takeyama H, Mohri N, et al. (1999) Retrospective study on patients with metachronous liver metastasis of gastric carcinoma after curative resection. In: Kim J-P (ed) Proceedings of Third International Gastric Cancer Congress; 1999 Apr 27-30; Seoul, Korea. Monduzzi Editore, Bologna, pp 821-824
3. Yonemura Y, Matuki N, Sakuma H, et al. (1992) Effects of intrahepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases. Jpn J Surg 22:253-259
4. Saji S, Aiba K, Araki H, et al. (1997) Current status of low-dose CDDP - 5-FU therapy for solid malignant tumors: nation-wide questionnaire survey (in Japanese with English abstract). Jpn J Cancer Chemother 24:1892-1900
5. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma, 2nd English edn. Gastric Cancer 1:10-24
6. Ochiai T, Sasako M, Mizuno S, et al. (1994) Hepatic resection for metastatic tumors from gastric cancer: analysis of prognostic factors. Br J Surg 81:1175-1178
7. Miyazaki M, Itoh H, Nakazawa K, et al. (1997) Hepatic resection of liver metastasis from gastric carcinoma. Am J Gastroenterol 92:490-493
8. Kondo K, Murase M, Kodera Y, et al. (1996) Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 53:64-67
9. Chung YS, Yamashita Y, Inoue T, et al. (1997) Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80:1-7
10. Scanlon KJ, Newman EM, Lu Y, et al. (1986) Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83:8923-8925
11. Sirasaka T, Shimamoto Y, Ohshima H, et al. (1993) Metabolic basis of the synergistic antitumor models in vivo. Cancer Chemother Pharmacol 32:167-172
12. Metzger R, Leichman CG, Danenberg KD, et al. (1998) ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol 16:309-316
13. Iba T, Yagi Y, Kidokoro A, et al. (1997) Intermittent low-dose cisplatin infusion as a possible modulator of 5-fluorouracil. Int J Clin Oncol 2:197-201
14. Hill TB (1983) Preclinical screening for drugs effective against 5-fluorouracil-resistant cells with a murine L5178Y cell line in vitro. J Natl Cancer Inst 71:335-340